Scollr summary
What this paper is about
Continuous 24-hour infusion of linezolid was associated with higher attainment rate of the pharmacokinetic/pharmacodynamic (PK/PD) target (AUC/MIC > 80) and higher clinical cure rate and no significant difference in mortality was observed between continuous and intermittent infusion.
Full abstract
Read the full abstract
Objective We aimed to compare the clinical cure profile of linezolid administered as continuous infusion (CI) vs. intermittent infusion (II), to provide practicable evidence for optimizing linezolid dosing. Method A systematic search of major electronic databases (PubMed, Cochrane Library, Web of Science, and Embase) was performed to identify randomized controlled trials (RCTs) that compared continuous versus intermittent infusion linezolid regimens, covering the period from database inception to 2026 April. After literature screening and data abstraction, the methodological quality of the eligible RCTs was appraised using the ROB-2 tool, and meta-analysis along with sensitivity analyses were performed via RevMan 5.4. Result Finally, 389 patients from 5 RCTs were finally analyzed. Meta-analysis demonstrated that compared with the II group, the CI group had substantially higher rates of both AUC/MIC > 80 attainment (RR = 1.91, 95% CI: 1.13–3.24, P = 0.02) and clinical cure (RR = 1.33, 95% CI: 1.14–1.54, P 80) and higher clinical cure rate. However, no significant difference in mortality was observed between continuous and intermittent infusion. Therefore, whether better PK/PD target attainment translated into better patient outcomes remained uncertain. Given these findings, larger-scale, multi-center RCTs focusing on linezolid dosing strategies are urgently warranted to corroborate these observations.
Direct answer
What can I do from this paper page?
Use this page to scan "Clinical outcomes of continuous versus intermittent linezolid infusion regimens: a systematic review and meta-analysis" quickly: start with the summary and abstract, then check the authors, source, topics, and related papers. From here, open Scollr to follow Antibiotics Pharmacokinetics and Efficacy research, save the paper, or map adjacent work.
Research areas
Follow related topics
Citation
BibTeX
@article{Ding2026Clinical,
title = {Clinical outcomes of continuous versus intermittent linezolid infusion regimens: a systematic review and meta-analysis},
author = {Yuzhen Ding and Xiaoshuai Wang and Yuanyuan Zhong and Ruya Li and Huiyu Ying and Xiang Lu and Jiajia Cai and Feiling Chen},
journal = {Frontiers in Medicine},
year = {2026},
doi = {10.3389/fmed.2026.1971024},
url = {https://doi.org/10.3389/fmed.2026.1971024}
}
FAQ
Using this paper in a discovery workflow
How do I find related work for this paper?
Use the related papers and topic links on this page as starting points. In Scollr, you can also open the paper and build a literature map around its references, citing papers, and related work.
How can I keep up with new Antibiotics Pharmacokinetics and Efficacy research papers?
Follow Antibiotics Pharmacokinetics and Efficacy research in Scollr. New papers from the topic flow into a personalized feed, and you can save useful studies to revisit later.
Can I cite this paper from this page?
This page includes a static BibTeX block for Clinical outcomes of continuous versus intermittent linezolid infusion regimens: a systematic review and meta-analysis. Always verify the DOI, source, and publication details against the publisher record before submitting a manuscript.
Follow this research in Scollr
Follow the topics and authors behind this paper, save useful studies, and build a literature map when you are ready to go deeper.
Get the app